CYNOSURE AESTHETIC AND MEDICAL APAC SERVICES PTE. LTD.
We are leaders, innovators, developers, and best-in-class creators of energy-based aesthetic and medical treatment systems. Cynosure develops and manufactures a diverse range of leading treatment applications for hair removal, skin revitalization, scar reduction, gynecological health, body contouring, and more.
See below for the Latest CYNOSURE AESTHETIC AND MEDICAL APAC SERVICES PTE. LTD. News, Analysis, Profit Results, Share Price Information, and Commentary.
Cynosure wins SBR International Business Awards 2024 with Groundbreaking Clinical Education Peer Programme
Cynosure wins SBR International Business Awards 2024 with Groundbreaking Clinical Education Peer Programme
Medical equipment manufacturing powerhouse Cynosure has clinched the prestigious SBR International Business Awards 2024 for Healthcare for its innovative Clinical Education Peer Programme for doctors in the region.
The future of medical aesthetics: Paving the way with innovative laser technology
With a commitment to building strategic partnerships and continuous research and development, Cynosure remains at the forefront of laser technology in medical aesthetics.
Resource Center
Read Here
Advertise
Sign Up
Awards
Sep
17
Oct
01
Nov
11
Feb
23
Event News
Organisations win customer confidence by consistently proving integrity and authenticity of every digital interaction.
Commentary
China’s leasing giants are growing up — and Asia’s banks can’t look away
Adapting to change with confidence
Why HR in Asia needs stronger culture governance, not louder transformation promises
Malaysian brands know what they want to be — their incentive structures disagree
Asia plays part in $129t global credit market pool
Rethinking the role of video infrastructure in Asian retail
Why APAC digital leaders must overhaul content amidst fractured consumer discovery
Why bigger digesters alone won't solve Asia's renewable energy challenge
Only the agile will win across ASEAN’s evolving markets
Scaling for resilience: What Asia Pacific’s bioenergy markets can learn from each other